COMPANY PROFILE

BioOra

Explore full profile

Cell therapy for every patient in need

Wellington, New ZealandFounded 2021Biotech & Life Sciences

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About BioOra

BioOra has developed a cell therapy manufacturing platform that is captital lite, high throughput and low cost per patient dose. This means we can accelerate getting both our own cell therapies and our partners to patients. Our platform ensures those cell therapies are affordable and therefore accessible to patients. Accessible treatments are commercially succesful treatments and create commercially succesful companies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Wellington, New Zealand
Employees: 54
Open positions: None listed
Dealroom signal: 60.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Cell Therapy, Techbio, biomanufacturing, NZ tech startup, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Jun 2026	$5M	—	Queensland Government · Government industry fund	↗
SERIES A✓Equity / VC	Sep 2025	$9.7M	$49M	Undisclosed	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

BioOra website traffic

Latest recorded traffic for BioOra is 1.8K monthly website visits, down 33.3% over the last three months. BioOra's team grew 217.6% over the past year.

Latest monthly visits1.8K 3-month web change-33.3% 1-year team growth+217.6%

Monthly website visitsApr 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
XDXDemicsHigh-density cell respiration technology for biomanufacturing	Monrovia, United States	Operational	19	$7.4M	$30M
RBRidge BiotechnologiesAI-enabled platform for precision enzyme and drug design	Palo Alto, United States	Operational
STShenzhen Cellbri Bio-Innovation TechnologyAutomated, flexible cell processing equipment for therapies	Ningbo, China	Operational
STSOMITE THERAPEUTICSSomite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies	Boston, United States	Operational
CBConstructive BioRealising the potential of genome rewriting to drive the next generation of bioprocesses and biopharmaceuticals	Cambridge, United Kingdom	Operational
PMProlific MachinesA biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future	Emeryville, United States	Operational
STScripta TherapeuticsAI-driven drug discovery modulating transcription factor activity	Oxford, United Kingdom	Operational
ABAvenue BiosciencesInnovative protein engineering solutions integrating biologics and machine learning for therapeutic advancements	Palo Alto, United States	Operational